Moligo Technologies and Cellectis Demonstrate Potential of Enzymatic Single-Stranded DNA for Non-Viral Gene Editing in Nature Communications

Nature Communications article shows highly efficient and scalable gene insertion of long, single-stranded DNA donor templates in hematopoietic stem cells STOCKHOLM, Nov. 21, 2025 /PRNewswire/ -- Moligo Technologies, a DNA synthesis company advancing gene therapies, announced today the...

Read More